Lupin Eyes Joining Others In Bidding For GSK's Older Drugs At Auction
This article was originally published in PharmAsia News
Executive Summary
Lupin is among a host of drug makers around the globe planning to bid by the end of the month on GlaxoSmithKline's older drugs in an auction, according to sources.